Addictions Therapeutics Market

Description

The size of the Addictions Therapeutics Market was estimated at US$ 9.14 billion in 2024 and is projected to reach US$ 14.49 billion by 2031, reflecting a CAGR of 7.3% through 2031 - 2031. The ongoing introduction of various therapeutics is anticipated to be a significant trend in the Addictions Therapeutics Market.

Analysis of the Addictions Therapeutics Market

Leaders, regulatory bodies, and NGOs are actively seeking innovative methods to raise awareness and combat the escalating issue of substance addiction. For example, the Council on Chemical Abuse engages in numerous state and national initiatives aimed at increasing awareness about substance misuse, recovery, and prevention.

The United Nations Office on Drugs and Crime (UNODC) spearheads a global campaign to highlight the significant societal challenges posed by illicit drugs, particularly among youth. The UNODC conducts various awareness initiatives worldwide and encourages individuals, the private sector, non-profit organizations, and member states to implement outreach programs against drug trafficking and abuse.

Additionally, in August 2023, a campaign was initiated in India to deter adolescents from vaping. This campaign aimed to propose effective solutions and enlisted expert assistance to develop impactful messaging about the harmful effects of vaping. It also sought to inform the public about the vaping ban in India and other nations, explaining the rationale behind such regulations.

Such awareness initiatives and governmental actions aimed at combating drug abuse and promoting treatments for various addictions are likely to drive market growth during the forecast period.

Overview of the Addictions Therapeutics Market

The global addictions therapeutics market is categorized by region into North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America. North America commands the largest market share, while the Asia Pacific region is the fastest-growing area. The growth in North America is primarily attributed to the entry of new market players, numerous product launches, and an increasing number of individuals with one or more substance addictions. Furthermore, the Asia Pacific region is experiencing rapid growth in addiction therapeutics, with China, India, and Japan being key contributors due to high narcotic consumption, extensive development of generic drugs for addiction treatment, and the rise of local companies. Additionally, investments in research and development (R&D) by multinational pharmaceutical firms are also propelling market growth.

Strategic Insights

Drivers and Opportunities in the Addictions Therapeutics Market

Increasing Collaborations Among Organizations to Boost Market Growth

Numerous organizations within the addictions therapeutics market are forming partnerships that enhance market growth. For instance, in September 2023, Click Therapeutics partnered with Indivior to develop and commercialize prescription digital therapeutics aimed at treating substance use disorders, beginning with Opioid Use Disorder (OUD). This collaboration will utilize a mobile application named CT-102, designed to fill significant gaps in OUD treatment, such as providing access to high-quality, personalized psychosocial support.

Similarly, in January 2023, Pear Therapeutics expanded its collaboration with outpatient addiction treatment clinics. Spero Health is now able to utilize Pear's reSET and reSET-O prescription digital therapeutics across 99 locations in five states, up from just 14 clinics in Kentucky. Thus, the increasing partnerships among organizations are driving the growth of the addictions therapeutics market.

Growing Demand for R&D from Contract Organizations - A Market Opportunity

In recent years, the pharmaceutical sector has seen a surge in outsourcing services, driven by factors such as the rising demand for pain medications, increased complexity of active pharmaceutical ingredients (APIs), and the need to lower development costs. Major pharmaceutical companies are outsourcing R&D activities to accelerate drug development while also reducing their costs.

Many pharmaceutical companies, including those producing addiction therapeutics, depend on contract research organizations (CROs) to lower the high fixed costs associated with in-house development and manufacturing. The growing complexity in developing new molecular entities (NMEs) has created a demand for specialized capabilities that companies prefer to outsource rather than manage internally. With an increase in drug approvals (the FDA approved 55 NMEs in 2023), there is a heightened demand for robust clinical development and outsourcing. Various biotechnology firms are leveraging CROs to enhance their drug candidate pipelines. The cost reductions in drug manufacturing through outsourcing are expected to present significant growth opportunities for market players, enabling them to maximize profit margins and remain competitive in the evolving addictions therapeutics market.

Segmentation Analysis of the Addictions Therapeutics Market

Key segments contributing to the analysis of the addictions therapeutics market include treatment type, drug type, treatment center, and distribution channel.

By treatment type, the addictions therapeutics market is divided into nicotine addiction treatment, alcohol addiction treatment, opioid addiction treatment, and treatment for other substance addictions. The nicotine addiction treatment segment held the largest market share in 2023.
In terms of drug type, the market is categorized into varenicline, bupropion, nicotine replacement products, buprenorphine, naltrexone, disulfiram, and others. The varenicline segment accounted for the largest market share in 2023.
Regarding treatment centers, the market is segmented into outpatient treatment centers, residential treatment centers, and inpatient treatment centers. The outpatient treatment center segment led the market in 2023.

Geographical Analysis of the Addictions Therapeutics Market

The geographical scope of the addictions therapeutics market report is primarily divided into five regions: North America, Asia Pacific, Europe, Middle East & Africa, and South America/South & Central America.

North America is the leading market for addiction therapeutics, with the US holding the largest market share, followed by Canada. The growth in North America is characterized by the entry of new market players, various product launches, and an increasing number of individuals with substance addictions. Market participants in the US are raising funds for addiction treatment. For example, in July 2023, Affect Therapeutics, a company innovating addiction treatment through digital technology, announced it raised US$16 million in a Series A funding round led by ARTIS Ventures, a TechBio-focused investment firm. The funds will be utilized to expand the company's programs nationally and enhance the Affect app through engineering advancements.

Scope of the Addictions Therapeutics Market Report

Recent Developments and News in the Addictions Therapeutics Market

The addictions therapeutics market is assessed by collecting both qualitative and quantitative data through primary and secondary research, which includes significant corporate publications, association data, and databases. Below are some recent developments in the addictions therapeutics market:

In January 2023, Hikma Pharmaceuticals PLC launched Naloxone Hydrochloride Injection, USP, 2mg/2mL, in prefilled syringe (PFS) form. This medication is intended for the emergency treatment of known or suspected opioid overdoses and is the third PFS product introduced. The injection is currently available in the US. (Source: Hikma Pharmaceuticals PLC, 2023)
In January 2022, Pfizer partnered with Swedish start-up Alex Therapeutics to enter the digital therapeutics market. Alex Therapeutics' AI-driven platform combines cognitive behavioral therapy (CBT) and Acceptance and Commitment Therapy (ACT) with AI to tailor care. Their partnership initially focuses on developing digital therapeutics for nicotine addiction treatment, starting in the German market. (Source: Pfizer, 2022)

Coverage and Deliverables of the Addictions Therapeutics Market Report

The report titled "Addictions Therapeutics Market Size and Forecast (2022-2030)" provides a comprehensive analysis of the market, covering the following areas:

Market size and forecast at global, regional, and country levels for all key market segments included in the scope
Market dynamics such as drivers, restraints, and key opportunities
Key future trends
Detailed PEST/Porter's Five Forces and SWOT analysis
Global and regional market analysis covering key trends, major players, regulations, and recent developments
Industry landscape and competition analysis including market concentration, heat map analysis, prominent players, and recent developments
Detailed company profiles

Product Code: TIPRE00015265

1. Introduction

1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
- 1.3.1 Addictions Therapeutics Market and By Treatment Type
- 1.3.2 Addictions Therapeutics Market and By Drug Type
- 1.3.3 Addictions Therapeutics Market and By Treatment Center
- 1.3.4 Addictions Therapeutics Market and By Distribution Channel
- 1.3.5 Global Addictions Therapeutics Market and By Geography

2. Addictions Therapeutics Market and Key Takeaways

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. Addiction Therapeutics Market and Market Landscape

4.1 Overview
4.2 PEST Analysis
- 4.2.1 North America and PEST Analysis
- 4.2.2 Europe and PEST Analysis
- 4.2.3 Asia-Pacific and PEST Analysis
- 4.2.4 Middle East and Africa (MEA)and PEST Analysis
- 4.2.5 South and Central America (SCAM) and PEST Analysis

5. Addiction Therapeutics Market and Key Market Dynamics

5.1 Market Drivers
- 5.1.1 Rising Addiction Among General Populace
- 5.1.2 Conduction of Awareness Campaigns
5.2 Market Restraint
- 5.2.1 Steeping Costs of Drug Development
5.3 Market Opportunity
- 5.3.1 Rising Demand for R and D from Contract Organizations
5.4 Future Trend
- 5.4.1 Consistent Launch of Therapeutics
5.5 Impact Analysis

6. Addiction Therapeutics Market and Global Analysis

6.1 Global Addictions Therapeutics Marker Revenue Forecast and Analysis
6.2 Global Addictions Therapeutics Market, By Geography - Forecast And Analysis
6.3 Market Positioning of Key Players

7. Addictions Therapeutics Marketand Treatment Type

7.1 Overview
7.2 Addictions Therapeutics Market Share, Treatment Type, 2024 and 2031 (%)
7.3 Nicotine Addiction Treatment
- 7.3.1 Overview
  - 7.3.1.1 Nicotine Addiction Treatment: Addictions Therapeutics Marketand Revenue and Forecast to 2031 (US$ million)
7.4 Alcohol Addiction Treatment
- 7.4.1 Overview
  - 7.4.1.1 Alcohol Addiction Treatment: Addictions Therapeutics Marketand Revenue and Forecast to 2031 (US$ million)
7.5 Opioid Addiction Treatment
- 7.5.1 Overview
  - 7.5.1.1 Opioid Addiction Treatment: Addictions Therapeutics Marketand Revenue and Forecast to 2031 (US$ million)
7.6 Other Substance Addiction Treatment
- 7.6.1 Overview
- 7.6.2 Other Substance Addiction Treatment: Addictions Therapeutics Marketand Revenue and Forecast to 2031 (US$ million)

8. Addictions Therapeutics Marketand Drug Type

8.1 Overview
8.2 Addictions Therapeutics Market Share, Drug Type, 2024 and 2031 (%)
8.3 Varenicline
- 8.3.1 Overview
  - 8.3.1.1 Varenicline: Addictions Therapeutics Marketand Revenue and Forecast to 2031 (US$ million)
8.4 Bupropion
- 8.4.1 Overview
  - 8.4.1.1 Bupropion: Addictions Therapeutics Marketand Revenue and Forecast to 2031 (US$ million)
8.5 Nicotine Replacement Products
- 8.5.1 Overview
  - 8.5.1.1 Nicotine Replacement Products: Addictions Therapeutics Marketand Revenue and Forecast to 2031 (US$ million)
8.6 Buprenorphine
- 8.6.1 Overview
  - 8.6.1.1 Buprenorphine: Addictions Therapeutics Marketand Revenue and Forecast to 2031 (US$ million)
8.7 Naltrexone
- 8.7.1 Overview
  - 8.7.1.1 Naltrexone: Addictions Therapeutics Marketand Revenue and Forecast to 2031 (US$ million)
8.8 Disulfiram
- 8.8.1 Overview
  - 8.8.1.1 Disulfiram: Addictions Therapeutics Marketand Revenue and Forecast to 2031 (US$ million)
8.9 Others
- 8.9.1 Overview
  - 8.9.1.1 Others: Addictions Therapeutics Marketand Revenue and Forecast to 2031 (US$ million)

9. Addictions Therapeutics Marketand Treatment Center

9.1 Overview
9.2 Addictions Therapeutics Market Share, Treatment Center, 2024 and 2031 (%)
9.3 Outpatient Treatment Center
- 9.3.1 Overview
  - 9.3.1.1 Outpatient Treatment Center: Addictions Therapeutics Marketand Revenue and Forecast to 2031 (US$ million)
9.4 Residential Treatment Center
- 9.4.1 Overview
  - 9.4.1.1 Residential Treatment Center: Addictions Therapeutics Marketand Revenue and Forecast to 2031 (US$ million)
9.5 Inpatient Treatment Center
- 9.5.1 Overview
  - 9.5.1.1 Inpatient Treatment Center: Addictions Therapeutics Marketand Revenue and Forecast to 2031 (US$ million)

10. Addictions Therapeutics Marketand Distribution Channel

10.1 Overview
10.2 Addictions Therapeutics Market Share, Distribution Channel, 2024 and 2031 (%)
10.3 Hospital Pharmacies
- 10.3.1 Overview
  - 10.3.1.1 Hospital Pharmacies: Addictions Therapeutics Marketand Revenue and Forecast to 2031 (US$ million)
10.4 Medical Stores
- 10.4.1 Overview
  - 10.4.1.1 Medical Stores: Addictions Therapeutics Marketand Revenue and Forecast to 2031 (US$ million)
10.5 Others
- 10.5.1 Overview
  - 10.5.1.1 Others: Addictions Therapeutics Marketand Revenue and Forecast to 2031 (US$ million)

11. Addiction Therapeutics Market Analysis and Forecasts To 2031 and Geographical Analysis

11.1 North America: Addiction Therapeutics Market
- 11.1.1 Overview
- 11.1.2 North America: Addiction Therapeutics Market, - Revenue and Forecast to 2031 (USD Million)
- 11.1.3 North America: Addiction Therapeutics Market, by Treatment Typeand Revenue and Forecast to 2031 (USD Million)
- 11.1.4 North America: Addiction Therapeutics Market, by Drug Type and Revenue and Forecast to 2031 (USD Million)
- 11.1.5 North America: Addiction Therapeutics Market, by Treatment Center and Revenue and Forecast to 2031 (USD Million)
- 11.1.6 North America: Addiction Therapeutics Market, by Distribution Channel and Revenue and Forecast to 2031 (USD Million)
- 11.1.7 North America: Addiction Therapeutics Market, by Country, 2024 and 2031 (%)
- 11.1.8 US: Addiction Therapeutics Market and Revenue and Forecast to 2031 (USD Million)
  - 11.1.8.1 US: Addiction Therapeutics Market and Revenue and Forecast to 2031 (USD Million)
  - 11.1.8.2 US: Addiction Therapeutics Market, by Treatment Type and Revenue and Forecast to 2031 (USD Million)
  - 11.1.8.3 US: Addiction Therapeutics Market, by Drug Type and Revenue and Forecast to 2031 (USD Million)
  - 11.1.8.4 US: Addiction Therapeutics Market, by Treatment Center and Revenue and Forecast to 2031 (USD Million)
  - 11.1.8.5 US: Addiction Therapeutics Market, by Distribution Channel and Revenue and Forecast to 2031 (USD Million)
- 11.1.9 Canada: Addiction Therapeutics Market and Revenue and Forecast to 2031 (USD Million)
  - 11.1.9.1 Canada: Addiction Therapeutics Market and Revenue and Forecast to 2031 (USD Million)
  - 11.1.9.2 Canada: Addiction Therapeutics Market, by Treatment Type and Revenue and Forecast to 2031 (USD Million)
  - 11.1.9.3 Canada: Addiction Therapeutics Market, by Drug Type and Revenue and Forecast to 2031 (USD Million)
  - 11.1.9.4 Canada: Addiction Therapeutics Market, by Treatment Center and Revenue and Forecast to 2031 (USD Million)
  - 11.1.9.5 Canada: Addiction Therapeutics Market, by Distribution Channel and Revenue and Forecast to 2031 (USD Million)
- 11.1.10 Mexico: Addiction Therapeutics Market and Revenue and Forecast to 2031 (USD Million)
  - 11.1.10.1 Mexico: Addiction Therapeutics Market and Revenue and Forecast to 2031 (USD Million)
  - 11.1.10.2 Mexico: Addiction Therapeutics Market, by Treatment Type and Revenue and Forecast to 2031 (USD Million)
  - 11.1.10.3 Mexico: Addiction Therapeutics Market, by Drug Type and Revenue and Forecast to 2031 (USD Million)
  - 11.1.10.4 Mexico: Addiction Therapeutics Market, by Treatment Center and Revenue and Forecast to 2031 (USD Million)
  - 11.1.10.5 Mexico: Addiction Therapeutics Market, by Distribution Channel and Revenue and Forecast to 2031 (USD Million)
11.2 Europe: Addiction Therapeutics Market
- 11.2.1 Overview
- 11.2.2 Europe: Addiction Therapeutics Market, - Revenue and Forecast to 2031 (USD Million)
- 11.2.3 Europe: Addiction Therapeutics Market, by Treatment Type and Revenue and Forecast to 2031 (USD Million)
- 11.2.4 Europe: Addiction Therapeutics Market, by Drug Type and Revenue and Forecast to 2031 (USD Million)
  - 11.2.4.1 Europe: Addiction Therapeutics Market, by Treatment Center and Revenue and Forecast to 2031 (USD Million)
- 11.2.5 Europe: Addiction Therapeutics Market, by Distribution Channel and Revenue and Forecast to 2031 (USD Million)
- 11.2.6 Europe: Addiction Therapeutics Market, by Country, 2024 and 2031 (%)
- 11.2.7 Germany: Addiction Therapeutics Market and Revenue and Forecast to 2031 (USD Million)
  - 11.2.7.1 Germany: Addiction Therapeutics Market and Revenue and Forecast to 2031 (USD Million)
  - 11.2.7.2 Germany: Addiction Therapeutics Market, by Treatment Type and Revenue and Forecast to 2031 (USD Million)
  - 11.2.7.3 Germany: Addiction Therapeutics Market, by Drug Type and Revenue and Forecast to 2031 (USD Million)
  - 11.2.7.4 Germany: Addiction Therapeutics Market, by Treatment Center and Revenue and Forecast to 2031 (USD Million)
  - 11.2.7.5 Germany: Addiction Therapeutics Market, by Distribution Channel and Revenue and Forecast to 2031 (USD Million)
- 11.2.8 UK: Addiction Therapeutics Market and Revenue and Forecast to 2031 (USD Million)
  - 11.2.8.1 UK: Addiction Therapeutics Market and Revenue and Forecast to 2031 (USD Million)
  - 11.2.8.2 UK: Addiction Therapeutics Market, by Treatment Type and Revenue and Forecast to 2031 (USD Million)
  - 11.2.8.3 UK: Addiction Therapeutics Market, by Drug Type and Revenue and Forecast to 2031 (USD Million)
  - 11.2.8.4 UK: Addiction Therapeutics Market, by Treatment Center and Revenue and Forecast to 2031 (USD Million)
  - 11.2.8.5 UK: Addiction Therapeutics Market, by Distribution Channel and Revenue and Forecast to 2031 (USD Million)
- 11.2.9 France: Addiction Therapeutics Market and Revenue and Forecast to 2031 (USD Million)
  - 11.2.9.1 France: Addiction Therapeutics Market and Revenue and Forecast to 2031 (USD Million)
  - 11.2.9.2 France: Addiction Therapeutics Market, by Treatment Type and Revenue and Forecast to 2031 (USD Million)
  - 11.2.9.3 France: Addiction Therapeutics Market, by Drug Type and Revenue and Forecast to 2031 (USD Million)
  - 11.2.9.4 France: Addiction Therapeutics Market, by Treatment Center and Revenue and Forecast to 2031 (USD Million)
  - 11.2.9.5 France: Addiction Therapeutics Market, by Distribution Channel and Revenue and Forecast to 2031 (USD Million)
- 11.2.10 Italy: Addiction Therapeutics Market and Revenue and Forecast to 2031 (USD Million)
  - 11.2.10.1 Italy: Addiction Therapeutics Market and Revenue and Forecast to 2031 (USD Million)
  - 11.2.10.2 Italy: Addiction Therapeutics Market, by Treatment Type and Revenue and Forecast to 2031 (USD Million)
  - 11.2.10.3 Italy: Addiction Therapeutics Market, by Drug Type and Revenue and Forecast to 2031 (USD Million)
  - 11.2.10.4 Italy: Addiction Therapeutics Market, by Treatment Center and Revenue and Forecast to 2031 (USD Million)
  - 11.2.10.5 Italy: Addiction Therapeutics Market, by Distribution Channel and Revenue and Forecast to 2031 (USD Million)
- 11.2.11 Spain: Addiction Therapeutics Market and Revenue and Forecast to 2031 (USD Million)
  - 11.2.11.1 Spain: Addiction Therapeutics Market and Revenue and Forecast to 2031 (USD Million)
  - 11.2.11.2 Spain: Addiction Therapeutics Market, by Treatment Type and Revenue and Forecast to 2031 (USD Million)
  - 11.2.11.3 Spain: Addiction Therapeutics Market, by Drug Type and Revenue and Forecast to 2031 (USD Million)
  - 11.2.11.4 Spain: Addiction Therapeutics Market, by Treatment Center and Revenue and Forecast to 2031 (USD Million)
  - 11.2.11.5 Spain: Addiction Therapeutics Market, by Distribution Channel and Revenue and Forecast to 2031 (USD Million)
- 11.2.12 Rest of Europe: Addiction Therapeutics Market and Revenue and Forecast to 2031 (USD Million)
  - 11.2.12.1 Rest of Europe: Addiction Therapeutics Market and Revenue and Forecast to 2031 (USD Million)
  - 11.2.12.2 Rest of Europe: Addiction Therapeutics Market, by Treatment Type and Revenue and Forecast to 2031 (USD Million)
  - 11.2.12.3 Rest of Europe: Addiction Therapeutics Market, by Drug Type and Revenue and Forecast to 2031 (USD Million)
  - 11.2.12.4 Rest of Europe: Addiction Therapeutics Market, by Treatment Center and Revenue and Forecast to 2031 (USD Million)
  - 11.2.12.5 Rest of Europe: Addiction Therapeutics Market, by Distribution Channel and Revenue and Forecast to 2031 (USD Million)
11.3 Asia Pacific: Addiction Therapeutics Market
- 11.3.1 Overview
- 11.3.2 Asia Pacific: Addiction Therapeutics Market - Revenue and Forecast to 2031 (USD Million)
- 11.3.3 Asia Pacific Addiction Therapeutics Market, by Treatment Typeand Revenue and Forecast to 2031 (USD Million)
- 11.3.4 Asia Pacific Addiction Therapeutics Market, by Drug Typeand Revenue and Forecast to 2031 (USD Million)
- 11.3.5 Asia Pacific Addiction Therapeutics Market, by Treatment Center and Revenue and Forecast to 2031 (USD Million)
- 11.3.6 Asia-Pacific: Addiction Therapeutics Market, by Distribution Channel and Revenue and Forecast to 2031 (USD Million)
- 11.3.7 Asia Pacific: Addiction Therapeutics Market, by Country, 2024 and 2031 (%)
- 11.3.8 China: Addiction Therapeutics Market and Revenue and Forecast to 2031 (USD Million)
  - 11.3.8.1 China: Addiction Therapeutics Market and Revenue and Forecast to 2031 (USD Million)
  - 11.3.8.2 China Addiction Therapeutics Market, by Treatment Typeand Revenue and Forecast to 2031 (USD Million)
  - 11.3.8.3 China Addiction Therapeutics Market, by Drug Typeand Revenue and Forecast to 2031 (USD Million)
  - 11.3.8.4 China Addiction Therapeutics Market, by Treatment Center and Revenue and Forecast to 2031(USD Million)
  - 11.3.8.5 China: Addiction Therapeutics Market, by Distribution Channel and Revenue and Forecast to 2031 (USD Million)
- 11.3.9 Japan: Addiction Therapeutics Market and Revenue and Forecast to 2031 (USD Million)
  - 11.3.9.1 Japan: Addiction Therapeutics Market and Revenue and Forecast to 2031 (USD Million)
  - 11.3.9.2 Japan Addiction Therapeutics Market, by Treatment Typeand Revenue and Forecast to 2031 (USD Million)
  - 11.3.9.3 Japan Addiction Therapeutics Market, by Drug Typeand Revenue and Forecast to 2031 (USD Million)
  - 11.3.9.4 Japan Addiction Therapeutics Market, by Treatment Center and Revenue and Forecast to 2031(USD Million)
  - 11.3.9.5 Japan: Addiction Therapeutics Market, by Distribution Channel and Revenue and Forecast to 2031 (USD Million)
- 11.3.10 India: Addiction Therapeutics Market and Revenue and Forecast to 2031 (USD Million)
  - 11.3.10.1 India: Addiction Therapeutics Market and Revenue and Forecast to 2031 (USD Million)
  - 11.3.10.2 India Addiction Therapeutics Market, by Treatment Typeand Revenue and Forecast to 2031 (USD Million)
  - 11.3.10.3 India Addiction Therapeutics Market, by Drug Typeand Revenue and Forecast to 2031 (USD Million)
  - 11.3.10.4 India Addiction Therapeutics Market, by Treatment Center and Revenue and Forecast to 2031(USD Million)
  - 11.3.10.5 India: Addiction Therapeutics Market, by Distribution Channel and Revenue and Forecast to 2031 (USD Million)
- 11.3.11 South Korea: Addiction Therapeutics Market and Revenue and Forecast to 2031 (USD Million)
  - 11.3.11.1 South Korea: Addiction Therapeutics Market and Revenue and Forecast to 2031 (USD Million)
  - 11.3.11.2 South Korea Addiction Therapeutics Market, by Treatment Typeand Revenue and Forecast to 2031 (USD Million)
  - 11.3.11.3 South Korea Addiction Therapeutics Market, by Drug Typeand Revenue and Forecast to 2031 (USD Million)
  - 11.3.11.4 South Korea Addiction Therapeutics Market, by Treatment Center and Revenue and Forecast to 2031(USD Million)
  - 11.3.11.5 South Korea: Addiction Therapeutics Market, by Distribution Channel and Revenue and Forecast to 2031 (USD Million)
- 11.3.12 Australia: Addiction Therapeutics Market and Revenue and Forecast to 2031 (USD Million)
  - 11.3.12.1 Australia: Addiction Therapeutics Market and Revenue and Forecast to 2031 (USD Million)
  - 11.3.12.2 Australia Addiction Therapeutics Market, by Treatment Typeand Revenue and Forecast to 2031 (USD Million)
  - 11.3.12.3 Australia Addiction Therapeutics Market, by Drug Typeand Revenue and Forecast to 2031 (USD Million)
- 11.3.13 Australia Addiction Therapeutics Market, by Treatment Center and Revenue and Forecast to 2031 (USD Million)
  - 11.3.13.1 Australia: Addiction Therapeutics Market, by Distribution Channel and Revenue and Forecast to 2031 (USD Million)
- 11.3.14 Rest of Asia Pacific: Addiction Therapeutics Market and Revenue and Forecast to 2031 (USD Million)
  - 11.3.14.1 Rest of Asia Pacific: Addiction Therapeutics Market and Revenue and Forecast to 2031 (USD Million)
- 11.3.15 Rest of Asia Pacific Addiction Therapeutics Market, by Treatment Typeand Revenue and Forecast to 2031 (USD Million)
- 11.3.16 Rest of Asia Pacific Addiction Therapeutics Market, by Drug Typeand Revenue and Forecast to 2031 (USD Million)
- 11.3.17 Rest of Asia Pacific Addiction Therapeutics Market, by Treatment Center and Revenue and Forecast to 2031(USD Million)
  - 11.3.17.1 Rest of Asia Pacific: Addiction Therapeutics Market, by Distribution Channel and Revenue and Forecast to 2031 (USD Million)
11.4 Middle East and Africa: Addiction Therapeutics Market
- 11.4.1 Overview
- 11.4.2 Middle East and Africa: Addiction Therapeutics Market - Revenue and Forecast to 2031 (US$ Million)
- 11.4.3 Middle East and Africa Addiction Therapeutics Market, by Treatment Typeand Revenue and Forecast to 2031 (USD Million)
- 11.4.4 Middle East and Africa Addiction Therapeutics Market, by Drug Typeand Revenue and Forecast to 2031 (USD Million)
- 11.4.5 Middle East and Africa Addiction Therapeutics Market, by Treatment Center and Revenue and Forecast to 2031(USD Million)
  - 11.4.5.1 Middle East and Africa: Addiction Therapeutics Market, by Distribution Channel and Revenue and Forecast to 2031 (USD Million)
- 11.4.6 Middle East and Africa: Addiction Therapeutics Market, by Country, 2024 and 2031 (%)
- 11.4.7 Saudi Arabia: Addiction Therapeutics Market and Revenue and Forecast to 2031 (USD Million)
  - 11.4.7.1 Saudi Arabia: Addiction Therapeutics Market and Revenue and Forecast to 2031 (USD Million)
  - 11.4.7.2 Saudi Arabia Addiction Therapeutics Market, by Treatment Typeand Revenue and Forecast to 2031 (USD Million)
  - 11.4.7.3 Saudi Arabia Addiction Therapeutics Market, by Drug Typeand Revenue and Forecast to 2031 (USD Million)
  - 11.4.7.4 Saudi Arabia Addiction Therapeutics Market, by Treatment Center and Revenue and Forecast to 2031(USD Million)
  - 11.4.7.5 Saudi Arabia: Addiction Therapeutics Market, by Distribution Channel and Revenue and Forecast to 2031 (USD Million)
- 11.4.8 UAE: Addiction Therapeutics Market and Revenue and Forecast to 2031 (USD Million)
  - 11.4.8.1 UAE: Addiction Therapeutics Market and Revenue and Forecast to 2031 (USD Million)
  - 11.4.8.2 UAE Addiction Therapeutics Market, by Treatment Typeand Revenue and Forecast to 2031 (USD Million)
  - 11.4.8.3 UAE Addiction Therapeutics Market, by Drug Typeand Revenue and Forecast to 2031 (USD Million)
  - 11.4.8.4 UAE Addiction Therapeutics Market, by Treatment Center and Revenue and Forecast to 2031(USD Million)
  - 11.4.8.5 UAE: Addiction Therapeutics Market, by Distribution Channel and Revenue and Forecast to 2031 (USD Million)
- 11.4.9 South Africa: Addiction Therapeutics Market and Revenue and Forecast to 2031 (USD Million)
  - 11.4.9.1 South Africa: Addiction Therapeutics Market and Revenue and Forecast to 2031 (USD Million)
  - 11.4.9.2 South Africa Addiction Therapeutics Market, by Treatment Typeand Revenue and Forecast to 2031 (USD Million)
  - 11.4.9.3 South Africa Addiction Therapeutics Market, by Drug Typeand Revenue and Forecast to 2031 (USD Million)
  - 11.4.9.4 South Africa Addiction Therapeutics Market, by Treatment Center and Revenue and Forecast to 2031(USD Million)
  - 11.4.9.5 South Africa: Addiction Therapeutics Market, by Distribution Channel and Revenue and Forecast to 2031 (USD Million)
- 11.4.10 Rest of Middle East and Africa: Addiction Therapeutics Market and Revenue and Forecast to 2031 (USD Million)
  - 11.4.10.1 Rest of Middle East and Africa: Addiction Therapeutics Market and Revenue and Forecast to 2031 (USD Million)
  - 11.4.10.2 Rest of Middle East and Africa Addiction Therapeutics Market, by Treatment Typeand Revenue and Forecast to 2031 (USD Million)
  - 11.4.10.3 Rest of Middle East and Africa Addiction Therapeutics Market, by Drug Typeand Revenue and Forecast to 2031 (USD Million)
  - 11.4.10.4 Rest of Middle East and Africa Addiction Therapeutics Market, by Treatment Center and Revenue and Forecast to 2031(USD Million)
  - 11.4.10.5 Rest of Middle East and Africa: Addiction Therapeutics Market, by Distribution Channel and Revenue and Forecast to 2031 (USD Million)
11.5 South and Central America: Addiction Therapeutics Market
- 11.5.1 Overview
- 11.5.2 South and Central America: Addiction Therapeutics Market and Revenue and Forecast to 2031 (USD Million)
- 11.5.3 South and Central America Addiction Therapeutics Market, by Treatment Typeand Revenue and Forecast to 2031 (USD Million)
- 11.5.4 South and Central America Addiction Therapeutics Market, by Drug Typeand Revenue and Forecast to 2031 (USD Million)
- 11.5.5 South and Central America Addiction Therapeutics Market, by Treatment Center and Revenue and Forecast to 2031(USD Million)
  - 11.5.5.1 South and Central America: Addiction Therapeutics Market, by Distribution Channel and Revenue and Forecast to 2031 (USD Million)
- 11.5.6 South and Central America: Addiction Therapeutics Market, by Country, 2024 and 2031 (%)
- 11.5.7 Brazil: Addiction Therapeutics Market and Revenue and Forecast to 2031 (USD Million)
  - 11.5.7.1 Brazil: Addiction Therapeutics Market and Revenue and Forecast to 2031 (USD Million)
  - 11.5.7.2 Brazil Addiction Therapeutics Market, by Treatment Typeand Revenue and Forecast to 2031 (USD Million)
  - 11.5.7.3 Brazil Addiction Therapeutics Market, by Drug Typeand Revenue and Forecast to 2031 (USD Million)
  - 11.5.7.4 Brazil Addiction Therapeutics Market, by Treatment Center and Revenue and Forecast to 2031(USD Million)
  - 11.5.7.5 Brazil: Addiction Therapeutics Market, by Distribution Channel and Revenue and Forecast to 2031 (USD Million)
- 11.5.8 Argentina: Addiction Therapeutics Market and Revenue and Forecast to 2031 (USD Million)
  - 11.5.8.1 Argentina: Addiction Therapeutics Market and Revenue and Forecast to 2031 (USD Million)
  - 11.5.8.2 Argentina Addiction Therapeutics Market, by Treatment Typeand Revenue and Forecast to 2031 (USD Million)
  - 11.5.8.3 Argentina Addiction Therapeutics Market, by Drug Typeand Revenue and Forecast to 2031 (USD Million)
  - 11.5.8.4 Argentina Addiction Therapeutics Market, by Drug Type and Revenue and Forecast to 2031(USD Million)
  - 11.5.8.5 Argentina: Addiction Therapeutics Market, by Distribution Channel and Revenue and Forecast to 2031 (USD Million)
- 11.5.9 Rest of South and Central America: Addiction Therapeutics Market and Revenue and Forecast to 2031 (USD Million)
  - 11.5.9.1 Rest of South and Central America: Addiction Therapeutics Market and Revenue and Forecast to 2031 (USD Million)
  - 11.5.9.2 Rest of South and Central America Addiction Therapeutics Market, by Treatment Typeand Revenue and Forecast to 2031 (USD Million)
  - 11.5.9.3 Rest of South and Central America Addiction Therapeutics Market, by Drug Typeand Revenue and Forecast to 2031 (USD Million)
  - 11.5.9.4 Rest of South and Central America Addiction Therapeutics Market, by Treatment Center and Revenue and Forecast to 2031(USD Million)
  - 11.5.9.5 Rest of South and Central America Addiction Therapeutics Market, by Distribution Channel and Revenue and Forecast to 2031(USD Million)

12. Impact of COVID-19 Pandemic on Global Addiction Therapeutics Market

12.1 North America: Impact Assessment of COVID-19 Pandemic
12.2 Europe: Impact Assessment Of COVID-19 Pandemic
12.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic
12.4 Rest of the World: Impact Assessment of COVID-19 Pandemic

13. Addictions Therapeutics Market and Industry Landscape

13.1 Overview
13.2 Growth Strategies Done by the Companies in the Market, (%)
13.3 Organic Developments
- 13.3.1 Overview
13.4 Inorganic Developments
- 13.4.1 Overview

14. Company Profiles

14.1 Indivior PLC
- 14.1.1 Key Facts
- 14.1.2 Business Description
- 14.1.3 Products and Services
- 14.1.4 Financial Overview
- 14.1.5 SWOT Analysis
- 14.1.6 Key Developments
14.2 Pfizer Inc.
- 14.2.1 Key Facts
- 14.2.2 Business Description
- 14.2.3 Products and Services
- 14.2.4 Financial Overview
- 14.2.5 SWOT Analysis
- 14.2.6 Key Developments
14.3 GlaxoSmithKline plc.
- 14.3.1 Key Facts
- 14.3.2 Business Description
- 14.3.3 Products and Services
- 14.3.4 Financial Overview
- 14.3.5 SWOT Analysis
- 14.3.6 Key Developments
14.4 Bausch Health Companies Inc.
- 14.4.1 Key Facts
- 14.4.2 Business Description
- 14.4.3 Products and Services
- 14.4.4 Financial Overview
- 14.4.5 SWOT Analysis
- 14.4.6 Key Developments
14.5 Cipla Inc.
- 14.5.1 Key Facts
- 14.5.2 Business Description
- 14.5.3 Products and Services
- 14.5.4 Financial Overview
- 14.5.5 SWOT Analysis
- 14.5.6 Key Developments
14.6 Orexo AB
- 14.6.1 Key Facts
- 14.6.2 Business Description
- 14.6.3 Products and Services
- 14.6.4 Financial Overview
- 14.6.5 SWOT Analysis
- 14.6.6 Key Developments
14.7 Purdue Pharma L.P.
- 14.7.1 Key Facts
- 14.7.2 Business Description
- 14.7.3 Products and Services
- 14.7.4 Financial Overview
- 14.7.5 SWOT Analysis
- 14.7.6 Key Developments
14.8 Alvogen
- 14.8.1 Key Facts
- 14.8.2 Business Description
- 14.8.3 Products and Services
- 14.8.4 Financial Overview
- 14.8.5 SWOT Analysis
- 14.8.6 Key Developments
14.9 Camurus AB
- 14.9.1 Key Facts
- 14.9.2 Business Description
- 14.9.3 Products and Services
- 14.9.4 Financial Overview
- 14.9.5 SWOT Analysis
- 14.9.6 Key Developments
14.10 Hikma Pharmaceuticals PLC
- 14.10.1 Key Facts
- 14.10.2 Business Description
- 14.10.3 Products and Services
- 14.10.4 Financial Overview
- 14.10.5 SWOT Analysis
- 14.10.6 Key Developments

15. Appendix

15.1 About The Insight Partners
15.2 Glossary of Terms